| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |